JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas

Seeking AlphaNov 20 00:06

Edgewise Therapeutics Insiders Sell US$2.6m Of Stock, Possibly Signalling Caution

Simply Wall StNov 11 21:00

Edgewise Therapeutics Is Maintained at Outperform by Wedbush

Dow JonesNov 8 23:36 · Ratings

RBC Capital Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $42

Futu NewsNov 8 20:31 · Ratings

Express News | Edgewise Therapeutics Inc : RBC Raises Target Price to $44 From $42

BreakingsNov 8 18:45

Edgewise Therapeutics Reports Q3 Progress in Muscle Disease Trials

TipRanksNov 8 14:01